HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case report of pulmonary aspergillosis in lung transplant recipient successfully treated with inhalation administration of liposomal amphotericin B].

Abstract
We report a case of pulmonary aspergillosis in lung transplant recipient who was successfully treated with inhalation administration of anti-fungal agent. The case was 33-year-old female. Two years ago, she had received lung transplant because of lymphangioleiomyomatosis. One year ago, she had diagnosed of pulmonary aspergillosis and successfully treated with micafungin and itraconazole. Then she had been continuous administered with itraconazole. In June 20xx, she had nausea and vomiting and was diagnosed of viral enteritis. Although abdominal symptoms were relieved, ground glass opacity was discovered in her right lung. Bronchoscopic examination revealed ulceration of bronchus with white necrotic substance. Laboratory culture test demonstrated Aspergillus spp. Finally she was diagnosed of recurrent pulmonary aspergillosis. First, she was treated with intravascular administration of micafungin. Then, inhalation administration of liposomal amphotericin B was changed. Ground glass opacity and bronchial region of pulmonary aspergillosis was improved. Thereafter, inhalation of amphotericin B was continued and no recurrence of pulmonary aspergillosis has been found. Inhalation of anti-fungal agent could be an option for pulmonary aspergillosis.
AuthorsMasaki Fujita, Jun Yanagisawa, Masafumi Hiratsuka, Takeshi Shiraishi, Ryosuke Hirano, Takemasa Matsumoto, Motokimi Shiraishi, Akinori Iwasaki, Kentaro Watanabe
JournalThe Japanese journal of antibiotics (Jpn J Antibiot) Vol. 66 Issue 1 Pg. 37-43 (Feb 2013) ISSN: 0368-2781 [Print] Japan
PMID23777015 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antifungal Agents
  • liposomal amphotericin B
  • Amphotericin B
Topics
  • Administration, Inhalation
  • Adult
  • Amphotericin B (administration & dosage)
  • Antifungal Agents (administration & dosage)
  • Female
  • Humans
  • Lung Transplantation (adverse effects)
  • Pulmonary Aspergillosis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: